Jon Kim Andrus, MD

Jon Andrus is Professor in the Department of Global Health and Director of the Global Health MPH Program.

• Phone: (202) 994-0988 or (202) 994-3799
• Fax: (202) 994-1955
• Email: andrusjonkim@gmail.com

A medical epidemiologist, Dr. Andrus has spent 25 years working in the fields of primary care, vaccines, and immunization in developing countries. Now a full-time SPHHS faculty member, he continues to serve as Lead Technical Advisor for the Comprehensive Family Immunization Project of the Pan American Health Organization. At PAHO, he provides technical oversight for vaccine and immunization-related policy development, serves as editor of the Immunization Newsletter, and is a member of its Task Force on Epidemic Alert and Response.

Dr. Andrus developed an early interest in global health as a Peace Corps volunteer in Malawi, Africa, where he served as the only physician in a district of 210,000 people. In subsequent years, his professional focus on polio eradication and other immunization-related projects has taken him around the world - including India, Southeast Asia, Nigeria, Zimbabwe, and South and Central America. Among his prior positions, Dr. Andrus has been a medical epidemiologist in the CDC's Global Immunization Division and head of the Vaccinology and Immunization Program at the Institute for Global Health at the University of California, San Francisco and Berkeley.

Before joining the School as full-time faculty, Dr. Andrus was an adjunct at the Department of Global Health, and continues to hold adjunct faculty positions at the University of California, San Francisco School of Medicine and the Johns Hopkins Bloomberg School of Public Health. In 2000, he received the Distinguished Service Medal, the highest award of the United States Public Health Service, for his leadership in working to eradicate polio in Southeast Asia. He was also awarded the Emil M. Mrak International Award of the University California, Davis, Cal Aggie Alumni Association.

Education

Bachelor of Science (Biological Science), Stanford University, 1975
Doctor of Medicine, University of California, Davis, 1979

Teaching

PubH 205: Policy Approaches to Public Health, Department of Global Health
PubH 327: Global Health Program Evaluation, Department of Global Health

Research

Dr. Andrus's widely published research focuses on accelerating control of vaccine-preventable diseases and developing policies to expedite the introduction of new vaccines in developing countries.

Community Service

Dr. Andrus serves on the Selection Committee of the Hubert Humphrey Fellowship Program and is a member of the Advisory Board of StandProud (formerly, International Polio Victims Response Committee). He is also a member of the Steering Committee for Cervical Cancer Action and a member of PATH's HPV Vaccine Project's Technical Advisory Group.

Departments

• Global Health

Publications

• Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
  Hendrickx G, Van Herck, Vorsters A, Wisma S, et al. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepatitis 2008;15 (Suppl 2):1-15.
• A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean.
  Luciani S, Andrus JK. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean. Reprod Health Matters 2008;16 (32):59-66.
• Introduction of HPV vaccine into developing countries: International strategies for financing and procurement.
  Andrus JK, Sherris J, Fitzsimmons JW, Kane MA, Aguado T. Introduction of HPV vaccine into developing countries: International strategies for financing and procurement. Vaccine 2008;26S:K87-92.
• Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
  Andrus JK, Lewis M, Goldie SJ, Winkler J, et al. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean. Vaccine 2008;26S:L80-L87.
• Integration of vaccination and cervical cancer screening in Latin America and the Caribbean.
  Franco EL, Tsu V, Herrero R, Lazcano E, et al. Integration of vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine 2008;26S:L88-L95.
• Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
  Goldie SJ, Sanchis MD, Constenia D, Alvis N, e al. Mathematical models of cervical cancer prevention in Latin America and the Caribbean. Vaccine 2008 26S:L59-72.
• Recommendations for cervical cancer prevention in Latin America and the Caribbean.
  Munoz N., Franco EL, Herrero R, Andrus JK, et al. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine 2008;26 (11):L96-107.
• Progress in vaccination against Hemphilus influenza Type b in the Americas.
  Danovaro-Holiday MC, Ropero AM, Andrus JK. Progress in vaccination against Hemphilus influenza Type b in the Americas. PLoS Medicine 2008;5(4):e87,530-6.
• Is global measles eradication feasible: Five years after the interruption of endemic measles transmision in the Americas.
  De Quadros CA, Andrus JK, Danovaro C, Castillo-Solorzano C. Is global measles eradication feasible: Five years after the interruption of endemic measles transmision in the Americas. Expert Rev Vaccines 2008;7(3)355-62.
• Rotavirus vaccine introduction in the Americas.
  Oliveira LH, Danovaro-Holliday C, Ruiz Matus C, Andrus JK. Rotavirus vaccine introduction in the Americas. Expert Rev Vaccines 2008;7(3):345-53.
• Immunization and the Millennium Development Goals: Progress and challenges in Latin America and the Caribbean.
  Andrus JK, Crouch A, Fitzsimmons J, Vicari A, Tambini G. Immunization and the Millennium Development Goals: Progress and challenges in Latin America and the Caribbean. Health Affairs 2008;27(2):487-93.
• Outbreak of severe gastroenteritis due to rotavirus associated with high mortality in Nicaragua, 2005: Would children at risk have recieved a vaccine?
  Amador JJ, Vicari A, Turcios RM, Melendez D AC, et al. Outbreak of severe gastroenteritis due to rotavirus associated with high mortality in Nicaragua, 2005: Would children at risk have recieved a vaccine? Pan Am J Public Health 2008;23(4):277-84.
• Comparison of detection of rubella-specific IgM and IgG in dried blood spots and sera collected during a rubella outbreak in Peru.
  Helfand RF, Cabezas C, Abernathy E, Castillo-Solarzano C, et al. Comparison of detection of rubella-specific IgM and IgG in dried blood spots and sera collected during a rubella outbreak in Peru. CVI 2007;14(11):1522-5.
• A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac Initiative.
  Andrus JK, Toscano C, Lewis M, Oliveira L, Ropero AM, et al. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac Initiative. Public Health Reports 2007;122(6):811-16.
• Global access: Deployment, use, and acceptance.
  Andrus JK, de Quadros CA. Global access: Deployment, use, and acceptance. Chapter in: Khan P, Gust I, Koff W, eds. AIDS Vaccine Development: Challenges and Opportunities. Norfolk, United Kingdom: Horizon Scientific Press February 2007; pp 133-37.
• The global inter-relatedness of disease control.
  Andrus JK, Vicari A, Tambini G, Roses Periago M. The global inter-relatedness of disease control. Lancet Infect Dis (Reflection and Reaction) 2007;7:176.
• Accelerating Policy, Deployment, and access to new and underutilized vaccines in developing countries.
  Andrus JK, Dietz V, Fitzsimmons JW, Castillo-Solorzano C. Accelerating Policy, Deployment, and access to new and underutilized vaccines in developing countries. Harvard Health Policy Review 2006;7(2):91-101.
• Burden of diarrheal disease among children in Honduras, 2000-2004: Estimates of the role of rotavirus.
  Solorzano Giron JO, Molina IB, Turcios-Ruiz RM, Quiroz Mejia CE, et al. Burden of diarrheal disease among children in Honduras, 2000-2004: Estimates of the role of rotavirus. Pan Am J Public Health 2006;20(6):377-84.
• Introduction of new and underutilized vaccines: Perspectives from the Americas.
  Andrus JK, Fitzsimmons J, de Quadros CA. Introduction of new and underutilized vaccines: Perspectives from the Americas. In: Andrus JK, de Quadros CA, eds. Recent advances in immunization, 2nd Edition. Washington DC: PAHO Press, December 2006;114-126.
• Vaccine Safety.
  Oliveira L, Castillo-Solarzano C, Pena J, Danovaro C, Andrus JK. Vaccine Safety. In: Andrus JK, de Quadros CA, editors. Recent advances in immunization, 2nd ed. Washington DC: PAHO Press; 2006. p. 64-79.
• Status of rubella and congenital rubella syndrome control globally and in the Americas. Implications of regional efforts on rubella elimination in the United States.
  Dayan GH, Hersh B, Castillo-Solorzano C, Rodriguez R, Andrus JK, Reef SE. Status of rubella and congenital rubella syndrome control globally and in the Americas. Implications of regional efforts on rubella elimination in the United States. JID 2006;43 (Suppl 3):S158-63.
• Measles.
  De Quadros CA, Hersh BS, Andrus JK. Measles. In: Tropical Infectious Diseases: Principles, Pathogens, and Practice 2nd ed. (2); 2006. p. 578-585.
• Regional group purchasing of vaccines: Review of the Pan American Health Organization Revolving Fund and the Gulf Cooperation Council Group Purchasing Program.
  DeRoeck D A, Bawazir SA, Carrasco P, Kaddar M, et al. Regional group purchasing of vaccines: Review of the Pan American Health Organization Revolving Fund and the Gulf Cooperation Council Group Purchasing Program. Inter J Health Plann Mgmt 2006;21:23-43.
• Regional programs for health: Immunization as a model for strengthening inter-country cooperation and control of infectious diseases.
  Tambini G, Andrus JK, Fitzsimmons JW, Roses Periago M. Regional programs for health: Immunization as a model for strengthening inter-country cooperation and control of infectious diseases. Pan Am J Public Health 2006;20 (1):54-9.
• Pnuemococcal disease and vaccination in the Americas: An agenda for accelerated vaccine introduction.
  Garcia S, Levine O, Cherian T, Gabastou J M, Andrus JK, Working Group Members. Pnuemococcal disease and vaccination in the Americas: An agenda for accelerated vaccine introduction. Pan Am J Public Health 2006;19 (5):340-8.
• (The revolving fund of PAHO: Sustaining immunization programs of the Latin America and the Caribbean. In: Vaccines, sera, and immunizations in Brazil.)
  Andrus JK, Fitzsimmons J, Carrasco P, di Fabio JL, et al. Fundo rotatorio de imunizacao de Opas: sustentabilidade de programas de imunizacao na America Latina e Caribe. En: Vacinas, soros, imunizacas no Brazil. (The revolving fund of PAHO: Sustaining immunization programs of the Latin America and the Caribbean. In: Vaccines, sera, and immunizations in Brazil.) Buse PM, Temorao JG, da Rocha Carvalheiro J. eds. Brazil: Editora Fiocruz; 2005. p 405-11.
• Introduction of new and under-utilized vaccines: Sustaining access, disease control, and infrastructure development.
  Andrus JK, Fitzsimmons JW. Introduction of new and under-utilized vaccines: Sustaining access, disease control, and infrastructure development. PLoS Med 2005;2 (10):e286.
• Consideraciones para la vacunacion en caso de una pandemia de influenza.
  Ropero Alvarez AM, Andrus JK. Consideraciones para la vacunacion en caso de una pandemia de influenza. Med UNAB 2005;8 (3):191-6.
• Progress in vaccination against hepatitis B in the Americas.
  Ropero AM, Danovaro-Holiday MC, Andrus JK. Progress in vaccination against hepatitis B in the Americas. J Clin Virol 2005;34 (Suppl 2):S14-9.
• Reducing the global burden of congenital rubella syndrome.
  Best J, Castillo-Salorzano C, Spika JS, Icenogle J, et al. Reducing the global burden of congenital rubella syndrome. J Infect Dis 2005;192:1890-7.
• Anticipating new vaccines in the Americas [editorial].
  Andrus JK, Tambini G, di Fabio JL, Roses Periago M. Anticipating new vaccines in the Americas [editorial]. Pan Am J Public Health 2004;16 (6):369-70.
• Rubella elimination and improving health care for women.
  Castillo-Solorzano C, Andrus JK. Rubella elimination and improving health care for women. Emerg Infect Dis 2004;10 (11):2017-21.
• International issues in immunization.
  Cochi SL, Shimp L, Gasse F, Andrus JK. International issues in immunization. Emerg Infect Dis [serial on the Internet]. 2004 November [date cited]. Available from http://www.cdc.gov/ncidod/EID/vol10no11/04-0624_06.htm.
• Rotavirus vaccines [editorial].
  Andrus JK. Rotavirus vaccines [editorial]. Lancet 2004;364:246.
• Elimination of rubella and congenital rubella syndrome in the Americas: another opportunity to address inequities in health [editorial].
  Andrus JK, Roses Periago M. Elimination of rubella and congenital rubella syndrome in the Americas: another opportunity to address inequities in health [editorial]. Pan Am J Public Health 2004;15 (3):145-6.
• El desarrollo de nuevas vacunas: generacion de informacion para la toma de deciciones [editorial].
  Castillo-Solorzano C, Andrus JK, Roses Periago M. El desarrollo de nuevas vacunas: generacion de informacion para la toma de deciciones [editorial]. Pan Am J Public Health 2004;15 (3):1-3.